Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.9100
-0.0400 (-4.21%)
At close: May 26, 2026, 4:00 PM EDT
0.8901
-0.0199 (-2.19%)
After-hours: May 26, 2026, 6:36 PM EDT
Aprea Therapeutics Employees
Aprea Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$15,412
Profits / Employee
-$1,494,353
Market Cap
10.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| BioLineRx | 24 |
| BioCardia | 21 |
| GeoVax Labs | 19 |
| Moleculin Biotech | 17 |
| Kiora Pharmaceuticals | 13 |
| BioVie | 13 |
| Intensity Therapeutics | 7 |
APRE News
- 12 days ago - Aprea Therapeutics price target lowered to $6 from $7 at Wedbush - TheFly
- 13 days ago - Aprea Therapeutics reports Q1 EPS (22c) vs. (66c) last year - TheFly
- 13 days ago - Aprea Therapeutics Earnings release: Q1 2026 - Filings
- 13 days ago - Aprea Therapeutics Quarterly report: Q1 2026 - Filings
- 13 days ago - Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 19 days ago - Aprea Therapeutics initiated with an Outperform at Oppenheimer - TheFly
- 26 days ago - Aprea Therapeutics Proxy statement: Proxy filing - Filings
- 26 days ago - Aprea Therapeutics Proxy statement: Proxy filing - Filings